AHC - Austco Healthcare Limited - Strawman: ASX share price, valuation, research and discussion

Top member reports

Company Report

Last edited 3 months ago

ranked

#25

Performance (40m)

-18.2% pa

Followed by

Straws

Sort by:

Recent

Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.

Become a member

#FY24 Results

Added 3 months ago

Austco released its full year results announcing Revenue of 58.2m, NPAT of 7.1m (tax offset by the last of its loses) and an order back log of 50m.

Is a re-rating on the cards?

#ASX Announcements

Added 4 months ago

ASX Trading Update – Financial Year ended 30 June 2024

Following Austco Healthcare Limited’s (ASX: AHC) third quarter trading update of 17 April 2024, Austco

Healthcare is pleased to provide a further trading update for the full financial year ended 30 June 2024.

On an unaudited basis Austco Healthcare expects full year FY24:

• Revenue to be approximately $58m which is a 38% increase on FY23 revenue of $42m; and

• EBITDA is expected to be in the range of $7.5m to $8.0m, being an increase of between 108% and

122% on FY23 EBITDA of $3.6m.

The Full Year audited results (Appendix 4E) are expected to be released on or before 29 August 2024.

APPROVED RELEASE BY THE BOARD.

Austco Healthcare Limited